Tobias Peikert MD
Critical Care Medicine, Pleural Disease, Thoracic Oncology
Assistant Professor, Internal Medicine, Mayo Medical School
Join to View Full Profile
200 1st St SwRochester, MN 55905
Phone+1 507-284-2511
Dr. Peikert is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Tobias Peikert is a pulmonologist in Rochester, MN and is affiliated with Mayo Clinic Hospital - Rochester. He received his medical degree from Other and has been in practice 20 years. He specializes in critical care medicine, pleural disease, and thoracic oncology and is experienced in interstitial lung disease, critical care medicine, general pulmonology, and thoracic oncology.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Pulmonary Disease and Critical Care Medicine, 2003 - 2007
Cleveland Clinic FoundationResidency, Internal Medicine, 1999 - 2002
OtherClass of 1997
Certifications & Licensure
MN State Medical License 2003 - 2026
OH State Medical License 2000 - 2022
American Board of Internal Medicine Critical Care Medicine- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Mayo Clinic Patient Lists, Mayo Clinic, 2014-2017
- CMS Meaningful Use Stage 2 Certification Mayo Clinic Incorporate Lab Results, Mayo Clinic, 2014-2017
- CMS Meaningful Use Stage 2 Certification Centricity Patient Online, GE Healthcare, 2014-2017
Clinical Trials
- Intrapleural Measles Virus Therapy in Patients With Malignant Pleural Mesothelioma Start of enrollment: 2011 Nov 01
- Do Your Genes Put You at a Higher Risk of Developing Mesothelioma Start of enrollment: 2011 Jun 01
Publications & Presentations
PubMed
- Long-Term Prognosis of Resected Stage 1 Lung Adenocarcinoma With Radiomics, Regionality, and Histopathologic Correlation.Abdelmohaymin Abdalla, Srinivasan Rajagopalan, Tobias Peikert, Jennifer M Boland, Nan Zhang
CHEST Pulmonary. 2025-12-01 - Lung cancer reoccurrence and mortality is accelerated with episodic hypoxemia.Fernando Figueroa, Emily Liu, Phillip Schulte, Patricio Escalante, Kaiser Lim
Respiratory Medicine. 2025-10-01 - Radiomics-based Prediction of Local Recurrence after Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer.Chioma P Ogbonna, William G Breen, Pierre Le Noach, Srinivasan Rajagopalan, Logan J Hostetter
Annals of the American Thoracic Society. 2025-08-01
Authored Content
- Current and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research FoundationOctober 2018
Press Mentions
Doctors Say These Are the Signs of a Secret Cancer, Including Pancreatic CancerDecember 21st, 2022- BCO Urban Group Seminar - Plotting the FutureJuly 15th, 2021
- Mesothelioma Research Grants Focus on ImmunotherapyJuly 12th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
